XML 59 R52.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Share-Based Compensation - Summary of the Option Unit Activity (Details)
$ / shares in Units, $ in Millions
 6 Months Ended
Jun. 30, 2024
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Weighted Average Remaining Contractual Term, Grants Vested 1 year 2 months 12 days
2021 Equity Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of units, grant outstanding beginning balance | shares 4,686,659
Number of grants, exercised | shares (19,624)
Number of grants, issued | shares 162,640
Number of grants, forfeited | shares (65,729)
Number of units, grant outstanding ending balance | shares 4,763,946
Number of grants, vested | shares 2,365,286
Number of grants, unvested | shares 2,398,660
Weighted average exercise price, grant outstanding beginning balance | $ / shares $ 13.61
Weighted average exercise price, grants issued | $ / shares 14.14
Weighted average exercise price, grants issued | $ / shares 15.82
Weighted average exercise price, forefeited | $ / shares 13.73
Weighted average exercise price, grant outstanding ending balance | $ / shares 13.68
Weighted average exercise price, grants vested | $ / shares 13.63
Weighted average exercise price, grants unvested | $ / shares $ 13.73
Weighted Average Remaining Contractual Term, Grants Outstanding 7 years 4 months 24 days
Weighted Average Remaining Contractual Term, Grants Vested 7 years 2 months 12 days
Aggregate Intrinsic Value, grants outstanding | $ $ 11.4
Aggregate Intrinsic Value, grants vested | $ $ 5.8
First Advantage Corporation [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of units, grant outstanding beginning balance | shares 1,915,252
Number of grants, exercised | shares (51,916)
Number of grants, forfeited | shares (16,978)
Number of units, grant outstanding ending balance | shares 1,846,358
Number of grants, vested | shares 823,498
Number of grants, unvested | shares 1,022,860
Weighted average exercise price, grant outstanding beginning balance | $ / shares $ 5.15
Weighted average exercise price, grants issued | $ / shares 5.46
Weighted average exercise price, forefeited | $ / shares 5.11
Weighted average exercise price, grant outstanding ending balance | $ / shares 5.15
Weighted average exercise price, grants vested | $ / shares 5.12
Weighted average exercise price, grants unvested | $ / shares $ 5.18
Weighted Average Remaining Contractual Term, Grants Outstanding 5 years 8 months 12 days
Weighted Average Remaining Contractual Term, Grants Vested 5 years 7 months 6 days
Aggregate Intrinsic Value, grants outstanding | $ $ 20.2
Aggregate Intrinsic Value, grants vested | $ $ 9.0